CN102697825A - Anti-aging health-care product - Google Patents
Anti-aging health-care product Download PDFInfo
- Publication number
- CN102697825A CN102697825A CN2012102264005A CN201210226400A CN102697825A CN 102697825 A CN102697825 A CN 102697825A CN 2012102264005 A CN2012102264005 A CN 2012102264005A CN 201210226400 A CN201210226400 A CN 201210226400A CN 102697825 A CN102697825 A CN 102697825A
- Authority
- CN
- China
- Prior art keywords
- parts
- care product
- aging
- aging health
- health product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to an anti-aging health-care product. According to the technical scheme, the anti-aging health-care product is characterized by being prepared from the following raw material drugs in parts by weight: 100 to 120 parts of astaxanthin, 60 to 80 parts of hypericum perforatum, 60 to 80 parts of passion flower, and 5 to 6 parts of gamma-aminobutyric acid. The invention starts from aging genes and pathology, and aims at strengthening immunity and reinforcing the body pathological resistance, so that the cell activity and blood vessel elasticity can be improved, the blood viscosity can be reduced, two important organs, nemaly heart and brain are protected maximally, and the Chinese medicaments which have remarkable antagonistic effect on the pathological changes in modern pharmacological tests are screened and have scientific prescription. The developed anti-aging health-care product can be eaten frequently by people.
Description
Technical field
The invention belongs to the Chinese medicine health care product field, relate to a kind of antidotal health product particularly.
Background technology
Aging is that a kind of natural process shows as structure and hypofunction, and adaptability and resistance go down.According to interrelated data statistics, in recent years, the middle age about 40 years old is suffered from the significantly rising of cardiovascular and cerebrovascular diseases such as myocardial infarction, cerebral hemorrhage, and the sickness rate of diseases such as coronary heart disease, hypertension, hyperlipidemia, diabetes also is tending towards rejuvenation.Chasing after its reason mainly is: young and middle-aged people is under the dual-pressure of work and life, and the physical ability that consumes excessively and overdraw makes histoorgan old and feeble in advance.The Along with people's growth in the living standard, people constantly seek and can have good health and a long life, and improve immunity, defeat various diseases, improve the method for physical function, to improve the quality of living.Therefore need continually develop the health product of integration of edible and medicinal herbs with anti-aging function.
Summary of the invention
In order to overcome the above problems, the present invention provides a kind of antidotal health product.
The technical scheme that the present invention adopts is: a kind of antidotal health product, process by following raw material medicaments in part by weight proportioning: astaxanthin 100-120 part, Herba Hyperici perforati 60-80 part, Herba Passiflorae Caeruleae 60-80 part, GABA 5-6 part.
Above-mentioned a kind of antidotal health product, preferred, process by following raw material medicaments in part by weight proportioning: 110 parts of astaxanthins, 70 parts of Herba Hyperici perforatis, 70 parts of Herba Passiflorae Caeruleaes, 5 parts of GABAs.
Above-mentioned antisenescence health product by behind the proportioning mix homogeneously, can be processed tablet, capsule or pill with crude drug.
Among the present invention,
Astaxanthin:Be the crayfish shell from the river, a kind of pink group carotene of finding in Concha Ostreae and the salmon, chemical name is 3,3 '-dihydroxy-4,4 '-diketo-β, β '-carotene can be blue or green, blue in vivo with protein bound.Antioxidation, defying age, antitumor, the effect of prevention cardiovascular and cerebrovascular disease are arranged.
Herba Hyperici perforati:Having another name called Herba Hyperici perforati, is the shrub that a kind of length has the yellow flower of the long oval type petal of cluster.Herba Hyperici perforati contains hypericin and Herba Hyperici perforati resin, and catecholamine and neurohumoral content of 5-hydroxy tryptamine class and ratio in the ability nervous system regulation are kept emotional stability.It can effectively improve insomnia that depression, anxiety cause, forgetful, symptom such as unset, and is a kind of pure born preparation.To the human body highly effective and safe.
Herba Passiflorae Caeruleae:Bitter in the mouth; Warm in nature.Be used for neuralgia, the insomnia, diseases such as menstrual pain and dysentery have anesthesia and sedation.Remove the wind heat clearing away, relieving cough and resolving phlegm.Control the wind heat giddy, the nasal obstruction watery nasal discharge.
GABA:It is GABA.GABA is an inhibitory nerve mediator very important among the central nervous system, and it is that a kind of naturally occurring non-protein groups becomes aminoacid, has extremely important physiological function; It can promote the reactivity of brain, nourishing the brain and improving intelligence, epilepsy; Hypnotic, the beauty treatment skin moistening delays the brain aging function; Can replenish human body inhibitory nerve mediator, have good blood pressure reduction effect.Promote the kidney function to improve and protective effect.Suppress fatty liver and obesity, the activation liver function.Every day, the gamma-aminobutyric acid of supplement trace helped the alleviation of heart and brain blood pressure, can promote the balance of amino acid metabolism in the human body again, regulated immunologic function.
The present invention starts with from the gene and the pathology of aging, is conceived to enhancing immunity, strengthens body disease-resistant change effect (particularly anticancer change effect), improves cytoactive and blood vessel elasticity; Reduce blood viscosity; Protect the heart, these two important organs of brain to greatest extent, filter out through modern pharmacology and check the Chinese medicine that above-mentioned pathological change is had obvious antagonism, scientific composition; This antisenescence health product of development, people can often eat.
In order to check the effect of antisenescence health product, done following test:
1. raising physical ability, the enhancing body anti-fatigue ability: randomly draw 40 mices of the same age, be divided into two groups, experimental group on the basis of the normal daily feedstuff of feeding feeding every day health product of the present invention once, the daily feedstuff of the normal feeding of matched group.After one month, under identical water temperature, do the swimming endurance experiment, the result shows average swimming continuance time: experimental group 50 minutes, matched group: 20 minutes.Explain that health product of the present invention have the enhancing body anti-fatigue ability.
2. enhancing immunity: follow the tracks of 30 routine patients, this 30 routine patient, immunity is low, and the weather i.e. flu that changes was slightly caught a cold once in average 1-2 month.2 of capsules of the present invention of per os hora somni every day (0.5g/ grain), take 2 months after, immunity improves, the variation that can resist weather, the number of times of catching a cold obviously reduces.
3. improve cytoactive and blood vessel elasticity: 35-45 year age bracket the women, old and feeble performance mainly contains: become coarse dark and gloomy, elasticity attenuation, corse sweat pore, wrinkle of anxious state of mind, insomnia, hypomnesis, menoxenia, hyposexuality, mastatrophy, skin deepened.Follow the tracks of the women of 50 these age brackets of example, 2 of capsules of the present invention of per os hora somni every day (0.5g/ grain), take 2 months after, sleep quality is good, sleep is dark, memory increase, eumenorrhea, skin are ruddy, glossy, skin is flexible, wrinkle reduces.
4. follow the tracks of patients with coronary heart disease 80 people, its tangible clinical symptoms: pareordia is uncomfortable, nervous heart beating, and sensation of oppression over the chest with shortness of breath, electrocardiogram show that myocardial ischemia changes.Be divided into 2 groups; 2 of experimental group per os hora somni every day capsules of the present invention (0.5g/ grain) when taking cardiotropic formulation; Observe after six months; Experimental group takes a turn for the better fully has 16 people (pareordia does not have uncomfortable symptom, and electrocardiogram was normal continuously in back three months), and (clinical symptoms and electrocardiogram change and all significantly alleviate 21 people that are clearly better.), unconverted 3 people of the state of an illness (clinical symptoms and electrocardiogram have no significant change); Matched group takes a turn for the better fully has 4 people, and what be clearly better has 18 people, 18 people's no changes.Show that health product of the present invention have the myocardial ischemia of improvement, safeguard the health-care effect of heart normal function.
5. follow the tracks of 30 routine hyperlipemic patients, under the prerequisite of refusing to obey medicament, 2 of capsules of the present invention of per os hora somni every day (0.5g/ grain) were observed after 2 each months, and blood viscosity reaches normal value.
The specific embodiment
1 one kinds of antidotal health product of embodiment
Process by following raw material medicaments in part by weight proportioning: 110 parts of astaxanthins, 70 parts of Herba Hyperici perforatis, 70 parts of Herba Passiflorae Caeruleaes, 5 parts of GABAs.
The above-mentioned raw materials medicine by proportioning, behind the mix homogeneously, is processed capsule, and the capsule specification is: 0.5 gram/grain.
2 one kinds of antidotal health product of embodiment
Process by following raw material medicaments in part by weight proportioning: 100 parts of astaxanthins, 60 parts of Herba Hyperici perforatis, 80 parts of Herba Passiflorae Caeruleaes, 5 parts of GABAs.
The above-mentioned raw materials medicine by proportioning, behind the mix homogeneously, is processed capsule, and the capsule specification is: 0.5 gram/grain.
3 one kinds of antidotal health product of embodiment
Process by following raw material medicaments in part by weight proportioning: 120 parts of astaxanthins, 80 parts of Herba Hyperici perforatis, 60 parts of Herba Passiflorae Caeruleaes, 6 parts of GABAs.
The above-mentioned raw materials medicine by proportioning, behind the mix homogeneously, is processed capsule, and the capsule specification is: 0.5 gram/grain.
Claims (3)
1. antidotal health product is characterized in that being processed by following raw material medicaments in part by weight proportioning:
Astaxanthin 100-120 part, Herba Hyperici perforati 60-80 part, Herba Passiflorae Caeruleae 60-80 part, GABA 5-6 part.
2. according to the described a kind of antidotal health product of claim 1, it is characterized in that processing: 110 parts of astaxanthins, 70 parts of Herba Hyperici perforatis, 70 parts of Herba Passiflorae Caeruleaes, 5 parts of GABAs by following raw material medicaments in part by weight proportioning.
3. claim 1 or 2 described antidotal health product is characterized in that processing tablet, capsule or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102264005A CN102697825B (en) | 2012-07-03 | 2012-07-03 | Anti-aging health-care product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102264005A CN102697825B (en) | 2012-07-03 | 2012-07-03 | Anti-aging health-care product |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102697825A true CN102697825A (en) | 2012-10-03 |
| CN102697825B CN102697825B (en) | 2013-12-18 |
Family
ID=46891072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102264005A Active CN102697825B (en) | 2012-07-03 | 2012-07-03 | Anti-aging health-care product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102697825B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103446569A (en) * | 2013-09-05 | 2013-12-18 | 李树森 | Formula and preparation method of astaxanthin with thrombolysis effect |
| CN104905112A (en) * | 2015-06-19 | 2015-09-16 | 青岛浩大海洋保健食品有限公司 | Ocean health capsule with effects of delaying senility |
| CN104905272A (en) * | 2015-06-19 | 2015-09-16 | 青岛浩大海洋保健食品有限公司 | Health astaxanthin capsule with effect of delaying senility |
| CN105879014A (en) * | 2014-10-23 | 2016-08-24 | 大连世纪新源技术开发有限公司 | Deuterium-depleted water (DDW) oral liquid with functions of invigorating kidney and preventing aging |
| CN105879015A (en) * | 2014-10-23 | 2016-08-24 | 大连世纪新源技术开发有限公司 | Deuterium depleted water (DDW) oral liquid capable of preventing cancer and aging |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1374128A (en) * | 2002-03-25 | 2002-10-16 | 湖北致远科技股份有限公司 | Jiudanhuanxincao herb capsule |
| CN101897377A (en) * | 2010-07-29 | 2010-12-01 | 北京电子科技职业学院 | Preparation method of high gamma-aminobutyric acid tea |
| CN102366078A (en) * | 2011-09-09 | 2012-03-07 | 浙江省海洋开发研究院 | Shrimp shell seafood flavoring and its preparation method |
-
2012
- 2012-07-03 CN CN2012102264005A patent/CN102697825B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1374128A (en) * | 2002-03-25 | 2002-10-16 | 湖北致远科技股份有限公司 | Jiudanhuanxincao herb capsule |
| CN101897377A (en) * | 2010-07-29 | 2010-12-01 | 北京电子科技职业学院 | Preparation method of high gamma-aminobutyric acid tea |
| CN102366078A (en) * | 2011-09-09 | 2012-03-07 | 浙江省海洋开发研究院 | Shrimp shell seafood flavoring and its preparation method |
Non-Patent Citations (1)
| Title |
|---|
| 白猛猛: "桑葚中花色苷和西番莲中黄酮苷的分离纯化和NMR鉴定", 《工程科技I辑》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103446569A (en) * | 2013-09-05 | 2013-12-18 | 李树森 | Formula and preparation method of astaxanthin with thrombolysis effect |
| CN105879014A (en) * | 2014-10-23 | 2016-08-24 | 大连世纪新源技术开发有限公司 | Deuterium-depleted water (DDW) oral liquid with functions of invigorating kidney and preventing aging |
| CN105879015A (en) * | 2014-10-23 | 2016-08-24 | 大连世纪新源技术开发有限公司 | Deuterium depleted water (DDW) oral liquid capable of preventing cancer and aging |
| CN104905112A (en) * | 2015-06-19 | 2015-09-16 | 青岛浩大海洋保健食品有限公司 | Ocean health capsule with effects of delaying senility |
| CN104905272A (en) * | 2015-06-19 | 2015-09-16 | 青岛浩大海洋保健食品有限公司 | Health astaxanthin capsule with effect of delaying senility |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102697825B (en) | 2013-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102697825B (en) | Anti-aging health-care product | |
| CN102362970B (en) | Traditional Chinese medicinal composition with gastrointestinal tract improvement function and preparation technology thereof | |
| CN103263012A (en) | Edible and pharmaceutical health-care foodstuff and preparation method thereof | |
| CN105396029A (en) | Traditional Chinese medicine healthcare preparation for conditioning sub-health state | |
| CN104606456A (en) | Health medicine for treating hypertension and hyperlipidemia | |
| CN101912562B (en) | Chinese medicinal composition for treating gastropathy | |
| KR102169673B1 (en) | Composition for preventing, improving or treating stress diseases comprising Platycodi Radix extract | |
| CN104189819B (en) | A kind of Chinese medicine preparation for being used to nurse one's health emotional health | |
| CN110604783A (en) | Traditional Chinese medicine composition beverage for treating insomnia and preparation method thereof | |
| CN104491423A (en) | Traditional Chinese medicine composition for stomach and duodenal bulbar ulcers | |
| CN105616937A (en) | Traditional Chinese medicine for treating diabetes | |
| CN104771699B (en) | It is a kind of to treat medicine of child tic disorder and preparation method thereof | |
| CN106389684A (en) | Orally-taking medicine for treating insomnia and production method thereof | |
| US10383904B2 (en) | Composition for improving health and quality of life of women containing ginseng berry extract | |
| CN106616595A (en) | Health-care food preparation having strong oxidation resistance and oxygen deficient resistance and application | |
| CN102335388B (en) | Chinese medicine composition for soothing liver, removing stagnation, stimulating appetite, and promoting digestion and preparation method thereof | |
| CN101559139A (en) | Prescription of pure traditional Chinese medicine preparation for preventing and curing neurasthenia insomnia and preparation method thereof | |
| CN110934908A (en) | Compound nutritional health product capable of increasing body temperature to prevent diseases | |
| CN104435653A (en) | Traditional Chinese medicine composition for treating functional vomiting | |
| CN104491591A (en) | Health-care tea used for depression | |
| CN104383449B (en) | Pharmaceutical composition for treating depression syndrome | |
| CN102716219A (en) | Health care product beneficial to sleeping | |
| CN102885956B (en) | A kind of sleeping Chinese medicine composition and preparation method thereof | |
| CN102335386B (en) | Chinese medicinal composition for dispersing qi depression, promoting appetite, removing stagnation and stopping pain and preparation method thereof | |
| CN107137656A (en) | A kind of Chinese medicine composition for treating pregnant depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |